NO895183L - Inhibering av cellulaer adhesjon. - Google Patents

Inhibering av cellulaer adhesjon.

Info

Publication number
NO895183L
NO895183L NO89895183A NO895183A NO895183L NO 895183 L NO895183 L NO 895183L NO 89895183 A NO89895183 A NO 89895183A NO 895183 A NO895183 A NO 895183A NO 895183 L NO895183 L NO 895183L
Authority
NO
Norway
Prior art keywords
cellular adhesion
adhesion inhibition
inhibition
cellular
dissemination
Prior art date
Application number
NO89895183A
Other languages
English (en)
Norwegian (no)
Other versions
NO895183D0 (no
Inventor
Gayle Crozier-Willi
Mathilde Fleith
Michael Buchanan
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of NO895183D0 publication Critical patent/NO895183D0/no
Publication of NO895183L publication Critical patent/NO895183L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Fodder In General (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO89895183A 1988-12-23 1989-12-21 Inhibering av cellulaer adhesjon. NO895183L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH4790/88A CH676909A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1988-12-23 1988-12-23

Publications (2)

Publication Number Publication Date
NO895183D0 NO895183D0 (no) 1989-12-21
NO895183L true NO895183L (no) 1990-06-25

Family

ID=4282587

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89895183A NO895183L (no) 1988-12-23 1989-12-21 Inhibering av cellulaer adhesjon.

Country Status (14)

Country Link
US (1) US5141958A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0374591B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP3284132B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE81985T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU622500B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2004332C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH676909A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE68903378T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2045363T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IE (1) IE62603B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO895183L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ231938A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PT (1) PT92690B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA899632B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994392A (en) * 1988-02-26 1999-11-30 Neuromedica, Inc. Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid
JP2782443B2 (ja) * 1988-12-26 1998-07-30 將純 吉原 抗エイズウィルス剤
US5354269A (en) * 1991-12-20 1994-10-11 Fibrogenex, Inc. Method for treating cancer resections
EP0711503A3 (en) * 1994-11-14 1997-11-26 Scotia Holdings Plc Milk fortified with GLA and/or DGLA
US6576636B2 (en) 1996-05-22 2003-06-10 Protarga, Inc. Method of treating a liver disorder with fatty acid-antiviral agent conjugates
ES2151277T3 (es) * 1996-05-22 2000-12-16 Protarga Inc Composiciones que comprenden conjugados de acido cis-docosahexaenoico y taxotere.
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
US5919815A (en) * 1996-05-22 1999-07-06 Neuromedica, Inc. Taxane compounds and compositions
US6107334A (en) * 1998-02-23 2000-08-22 Wake Forest University Dietary control of arachidonic acid metabolism
US7138431B1 (en) * 1998-02-23 2006-11-21 Wake Forest University Dietary control of arachidonic acid metabolism
US6440448B1 (en) 1998-03-16 2002-08-27 Joseph Intelisano Food supplement/herbal composition for health enhancement
US7235583B1 (en) * 1999-03-09 2007-06-26 Luitpold Pharmaceuticals, Inc., Fatty acid-anticancer conjugates and uses thereof
AU4073800A (en) * 1999-04-05 2000-10-23 Wake Forest University Oxidized polyunsaturated fatty acids having anti-proliferative activity and methods of use
CA2304906A1 (en) * 2000-04-07 2001-10-07 1411198 Ontario Limited 13-hode, a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
JP4634694B2 (ja) * 2001-03-23 2011-02-16 ルイトポルド・ファーマシューティカルズ・インコーポレーテッド 脂肪アルコール薬物複合体
US8552054B2 (en) * 2001-03-23 2013-10-08 Luitpold Pharmaceuticals, Inc. Fatty amine drug conjugates
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
CN102458433B (zh) * 2009-05-29 2017-02-15 吉布控股（纳尔逊）有限公司 一种含有黑加仑子或波森莓的补充剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2490631A1 (fr) * 1980-09-24 1982-03-26 Roussel Uclaf Nouvelle composition lipidique utilisable en dietetique, reanimation et therapeutique
EP0092076B1 (fr) * 1982-04-16 1986-12-17 Societe Des Produits Nestle S.A. Composition lipidique destinée à l'alimentation orale, entérale ou parentérale
DE3366530D1 (en) * 1982-04-29 1986-11-06 Efamol Ltd Pharmaceutical composition
CH673223A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1987-10-16 1990-02-28 Nestle Sa

Also Published As

Publication number Publication date
US5141958A (en) 1992-08-25
CA2004332A1 (en) 1990-06-23
JP3284132B2 (ja) 2002-05-20
ATE81985T1 (de) 1992-11-15
ZA899632B (en) 1990-09-26
EP0374591A1 (fr) 1990-06-27
IE893878L (en) 1990-06-23
CH676909A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1991-03-28
AU4554789A (en) 1990-06-28
DE68903378T2 (de) 1993-05-06
PT92690A (pt) 1990-06-29
JPH02221228A (ja) 1990-09-04
NZ231938A (en) 1992-07-28
DE68903378D1 (de) 1992-12-10
EP0374591B1 (fr) 1992-11-04
IE62603B1 (en) 1995-02-22
AU622500B2 (en) 1992-04-09
PT92690B (pt) 1995-12-29
ES2045363T3 (es) 1994-01-16
NO895183D0 (no) 1989-12-21
CA2004332C (en) 2000-07-18

Similar Documents

Publication Publication Date Title
NO895183L (no) Inhibering av cellulaer adhesjon.
EP0715619A4 (en) Inhibitors of tnf-alpha secretion
DE3689363D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung der Metastasen von Krebstumoren.
NO894296D0 (no) Fremgangsmaate for behandling av leddgikt og betennelsessykdommer.
DK0912192T3 (da) Administration af GM-CSF til behandling af hjernetumorer og forebyggelse af sådanne tumorers tilbagevenden
BG42837A3 (bg) Метод за получаване на имуноглобулинови производни на винка алкалоиди
NO901141L (no) Additiv og fremgangsmaate for behandling av underjordiske formasjoner.
IT1237695B (it) Tubazioni di raccordo e fasci composti da tali tubazioni
KR930702896A (ko) 종양괴사인자 억제제
NO881436D0 (no) Fremgangsmaate for matriksbehandling av en oljebroenn.
ATE143808T1 (de) Proteintyrosinphosphatase alpha - inhibitoren zur tumorbehandlung
SE7706122L (sv) 2-imino-3-aminotiazolidiner
NO913995D0 (no) Inhibitorer for dannelse av tumornekrosefaktor samt fremgangsmaate og anvendelse derav
NO932052L (no) Faste doseringsformer av almokalant og fremgangsmaater forfremstilling derav
ES2039516T3 (es) Empleo de los enantiomeros de la propafenona para la obtencion de medicamentos.
NO885193D0 (no) Sammensetninger og fremgangsmÿte for tilveiebringing av prevensjon og kontroll av brystkreft.
FI913531A7 (fi) 1,2-bentsopyronijohdannaisten käyttö ihmisen pahanlaatuisten kasvainte n hoitoon
EP0518706A3 (en) An inbihiting agent against proliferation of malignant tumour cells of animals (including human beings)and methods for its manufacture
DE59108793D1 (de) Orthopädischer Mass- und Therapieschuhe
SE8802931D0 (sv) 5-pyrimidinecarboxamides and treatment of leukemia and tumors therewith
NO920396D0 (no) Galvanisk utfelt kobberfolie og fremgangsmaate for fremstilling av denne
NO880273L (no) Fremgangsmaate og anordning for stimulering av oljebroennerunder utnyttelse av lydboelger.
NO880738D0 (no) Blokkpolymer og anvendelse av denne.
NO931578D0 (no) Anordning og fremgangsmaate for montering av en vinkelformet union-skjoet
NO880436L (no) Fremgangsmaate for inhibering av benresorpsjon og kollagenasefrigivelse.